DCF Advisers »

Teva Pharmaceutical Industries shares owned by DCF Advisers

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by DCF Advisers

Quarter filed Position value Share count Share price at filing
2023-09-30 $454k 45k 10.20
2023-06-30 $294k 39k 7.53

More positions owned by DCF Advisers

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Micron Technology (MU)
Argenx Se Sponsored Adr (ARGX)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Intra Cellular Therapies (ITCI)
Oracle Corporation (ORCL)
Spdr Gold Tr Gold Shs (GLD)
Energy Transfer Com Ut Ltd Ptn (ET)
Xencor (XNCR)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Sponsored Ads (BABA)
Prothena Corp SHS (PRTA)

View all positions for DCF Advisers

Top funds holding Teva Pharmaceutical Industries

BlackRock
Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Clal Insurance Enterprises Holdings
Rubric Capital Management
Millennium Management
Citigroup
Citadel Advisors
AustralianSuper Pty
Susquehanna International
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management

View all funds holding Teva Pharmaceutical Industries